VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,333,911 | -7.2% | 2,358,418 | +8.7% | 0.00% | 0.0% |
| Q2 2023 | $34,830,651 | +218.3% | 2,170,134 | +53.9% | 0.00% | – |
| Q1 2023 | $10,943,695 | -35.4% | 1,410,270 | +61.0% | 0.00% | -100.0% |
| Q4 2022 | $16,948,355 | +0.6% | 875,884 | +10.8% | 0.00% | 0.0% |
| Q3 2022 | $16,852,000 | +72.7% | 790,795 | +10.3% | 0.00% | – |
| Q2 2022 | $9,759,000 | -38.9% | 717,034 | +5.5% | 0.00% | – |
| Q1 2022 | $15,965,000 | +31.3% | 679,675 | +49.3% | 0.00% | – |
| Q4 2021 | $12,161,000 | +123.2% | 455,100 | +44.9% | 0.00% | – |
| Q3 2021 | $5,449,000 | +68012.5% | 314,037 | +52857.3% | 0.00% | – |
| Q2 2021 | $8,000 | – | 593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
| Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
| Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
| Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
| Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
| Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
| Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
| Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |